285 related articles for article (PubMed ID: 16047948)
1. Hybrid chromophobe renal cell neoplasm.
Mai KT; Dhamanaskar P; Belanger E; Stinson WA
Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
[TBL] [Abstract][Full Text] [Related]
2. Chromophobe cell carcinoma and renal cell neoplasms with mucin-like changes.
Mai KT; Burns BF
Acta Histochem; 2000 Feb; 102(1):103-13. PubMed ID: 10726169
[TBL] [Abstract][Full Text] [Related]
3. Hybrid tumour 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases.
Delongchamps NB; Galmiche L; Eiss D; Rouach Y; Vogt B; Timsit MO; Vieillefond A; Méjean A
BJU Int; 2009 May; 103(10):1381-4. PubMed ID: 19154497
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas.
Wu SL; Kothari P; Wheeler TM; Reese T; Connelly JH
Mod Pathol; 2002 Jul; 15(7):712-7. PubMed ID: 12118108
[TBL] [Abstract][Full Text] [Related]
5. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
[TBL] [Abstract][Full Text] [Related]
6. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
7. Chromophobe renal cell carcinoma: a morphologic and immunohistochemical study of 45 cases.
Din NU; Fatima S; Ahmad Z
Ann Diagn Pathol; 2013 Dec; 17(6):508-13. PubMed ID: 24095630
[TBL] [Abstract][Full Text] [Related]
8. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
9. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.
Cochand-Priollet B; Molinié V; Bougaran J; Bouvier R; Dauge-Geffroy MC; Deslignières S; Fournet JC; Gros P; Lesourd A; Saint-André JP; Toublanc M; Vieillefond A; Wassef M; Fontaine A; Groleau L
Arch Pathol Lab Med; 1997 Oct; 121(10):1081-6. PubMed ID: 9341588
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
[TBL] [Abstract][Full Text] [Related]
12. Renal oncocytosis.
Nagashima Y; Mitsuya T; Shioi KI; Noguchi S; Kishida T; Hamano A; Ohgo Y; Tsuura Y; Ogawa T; Aoki I; Yao M
Pathol Int; 2005 Apr; 55(4):210-5. PubMed ID: 15826248
[TBL] [Abstract][Full Text] [Related]
13. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
14. Oncocytic renal cell carcinoma with immunohistochemical properties of renal oncocytoma.
Mai KT; Bicamumpaka C; Robertson SJ; Marginean CE; Belanger EC
Pathol Res Pract; 2009; 205(2):119-24. PubMed ID: 18947937
[TBL] [Abstract][Full Text] [Related]
15. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas.
Kuroda N; Toi M; Yamamoto M; Miyazaki E; Hayashi Y; Hiroi M; Shuin T; Enzan H
Histol Histopathol; 2004 Jan; 19(1):23-8. PubMed ID: 14702167
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].
Xie B; Cheng LC; Yin GL; Liu BA; Hu ZL; Tong K
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):719-725. PubMed ID: 35922161
[No Abstract] [Full Text] [Related]
18. Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.
Pires-Luis A; Montezuma D; Vieira J; Ramalho-Carvalho J; Santos C; Teixeira M; Jerónimo C; Henrique R
Exp Mol Pathol; 2018 Dec; 105(3):352-356. PubMed ID: 30343009
[TBL] [Abstract][Full Text] [Related]
19. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
Conner JR; Hirsch MS; Jo VY
Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
[TBL] [Abstract][Full Text] [Related]
20. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma.
Leroy X; Moukassa D; Copin MC; Saint F; Mazeman E; Gosselin B
Eur Urol; 2000 Apr; 37(4):484-7. PubMed ID: 10765081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
